Search clinical trials for: insulin administration

Total 15646 results

Geropharm

Completed

Comparative Study of the Pharmacokinetics of Rinsulin® Mix 30/70, Suspension for Subcutaneous Administration, 100 IU / ml (OJSC GEROPHARM-Bio, Russia) and Humulin® M3, Suspension for Subcutaneous Administration, 100 IU / ml (Lilly France, France) Using the Euglycemic Hyperinsulinemic Clamp Method

Bioequivalence

Russian Federation
Assaf-Harofeh Medical Center

Unknown

RCT for Evaluation of Insulin Administration,While Using the iPORT System

T1DM
Eli Lilly and Company
Insulet Corporation

Completed

An Administration Method Study of Human Regular U-500 Insulin (LY041001) in Participants With Type 2 Diabetes Mellitus (VIVID)

Type 2 Diabetes Mellitus

United States, Puerto Rico
Coordinación de Investigación en Salud, Mexico

Completed

Oral Curcumin Administration to Remit Metabolic Syndrome

Metabolic Syndrome

Mexico
McGill University
Juvenile Diabetes Research Foundation

Completed

Effect of Basal-Bolus Closed-Loop Co-Administration of Insulin and Pramlintide on Improving the Glycemic Control in Type 1 Diabetes

Diabetes Mellitus, Type 1

Canada
MDM S.p.A.
Opera CRO, a TIGERMED Group Company

Completed

Non-Comparative Study to Assess the Efficacy and Safety of the New Food Supplement FaseMETS

Metabolic Syndrome

Romania
LI ZHAO

Completed

Acute Effects of rhBNP in Patients With PH Associated With Acute Exacerbation of Chronic Pulmonary Disease

Pulmonary Hypertension

China
Catholic University of the Sacred Heart
Steno Diabetes Center Copenhagen

Completed

Insulin Sensitivity and Metabolomics During Oral Administration of Glucose and Graded Intravenous Infusion

Type 2 Diabetes Mellitus

Italy
Filip Krag Knop
Steno Diabetes Center Copenhagen

Completed

Meal-time Administration of Exenatide for Glycaemic Control in Type 1 Diabetic Cases (MAG1C)

Diabetes Mellitus, Type 1

Denmark
Cedars-Sinai Medical Center

Completed

Growth Hormone Feedback to Insulin-like Growth Factor-I (IGF-1) and Oral Glucose Tolerance Test (OGTT)

Type 2 Diabetes Mellitus | Acromegaly

United States
Patrice D. Cani
Cliniques universitaires Saint-Luc- Université Catholique de Louvain

Completed

Evaluation of the Effects Associated With the Administration of Akkermansia Muciniphila on Parameters of Metabolic Syndrome (Microbes4U)

Glucose Metabolism Disorders | Obesity | Dyslipidemias | Metabolic Syndrome x

Belgium
Dose Safety Inc.
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); Benaroya...

Suspended

Dose Safety Hybrid Closed Loop and Fully Automated Closed Loop Artificial Pancreas Device in CRC

Glucose, Low Blood | Glucose, High Blood

United States
Massachusetts General Hospital
Boston University

Completed

Closed-Loop Glucagon Administration For Hypoglycemia Treatment

Type 1 Diabetes

United States
Nermina Rizvanović

Completed

Preoperative Administration of Oral Carbohydrate Drink and Postoperative Insulin Resistance

Insulin Resistance | Inflammatory Response | Length of Stay | Exaggerated Well-Being

Bosnia and Herzegovina
University of Cambridge
University Hospital Inselspital, Berne; Cambridge University Hospitals NHS...

Completed

Closed-loop Insulin Delivery in the General Ward (ANGIE02)

Diabetes Mellitus

United Kingdom, Switzerland
Merck Sharp & Dohme LLC
Pfizer

Completed

Ertugliflozin and Sitagliptin Co-administration Factorial Study (VERTIS FACTORAL, MK-8835-005)

Type 2 Diabetes Mellitus
Boston Children's Hospital

Completed

Closed-Loop Insulin Delivery in Children Less Than 7 Years of Age

Type 1 Diabetes Mellitus

United States
Hoffmann-La Roche

Completed

A Study of Oseltamivir (Tamiflu) for Treatment of Influenza in Immunocompromised Participants.

Influenza, Human

United States, Spain, Belgium, Poland, Germany, United Kingdom, Chile, Estonia, Hungary, Italy, France, South Africa, Mexico, Israel, Brazil, Guatemala, Czechia, Lithuania, Argentina, Bulgaria, Canada, Colombia, Latvia, Romania, Switzer... and more
Joslin Diabetes Center
Juvenile Diabetes Research Foundation

Completed

Effect of Gain on Closed-Loop Insulin

Type 1 Diabetes

United States
Vanderbilt-Ingram Cancer Center
National Cancer Institute (NCI)

Completed

ALL-Active: A Family-Based Lifestyle Program for Pediatric Acute Leukemia Patients

Childhood Acute Lymphoblastic Leukemia in Remission

United States
AdventHealth Translational Research Institute

Completed

Effects of Glucagon Administration on Energy Expenditure (GLEE)

Obesity | Hyperglucagonemia

United States
Oshadi Drug Administration

Completed

Efficacy Safety and Tolerability of Multiple Doses of Oshadi Icp (Oshadi Oral Insulin) in Patients With Type 1 Diabetes Mellitus - Phase II Clinical Study

Diabetes Mellitus | Insulin-Dependent | Type 1

Israel
Turku University Hospital
University Hospital Tuebingen

Completed

Effects of Intranasal Insulin Administration on Tissue Specific Insulin Sensitivity (NASO-PET)

Insulin Resistance

Finland
Hospices Civils de Lyon

Terminated

Individualized Blood Glucose Control in ICU. The CONTROLING Study. A Double Blinded Multicentric Randomized Study. (CONTROLING)

Critical Illness

France
Stanford University
National Institute of General Medical Sciences (NIGMS)

Completed

Adiponectin Polymorphisms, Insulin Resistance, and Pharmacokinetics in Obesity

Obesity

United States
Peking Union Medical College Hospital
The First Affiliated Hospital with Nanjing Medical University; Guangdong Provincial... and other collaborators

Unknown

Intravenous Administration of Insulin and Plasma Exchange on Triglyceride Levels in Early Stage of Hypertriglyceridemia-induced Pancreatitis

Hypertriglyceridemia | Pancreatitis, Acute
Johns Hopkins University

Terminated

Glycemic Effects of Morning Only, Evening Only or Twice Daily Insulin Glargine in Patients With Type 1 Diabetes

Hypoglycemia | Type 1 Diabetes

United States
University of Roma La Sapienza

Unknown

Effect of Allopurinol on Mono and Co-administration With Statins on Platelets Reactivity on Diabetic Patiets Treated With Aspirin and Insulin

Diabetes Mellitus Type 2 Platelets Reactivity Statin

Italy
University of North Carolina, Chapel Hill
Laboratory Corporation of America; IntraPump Infusion Systems

Completed

Once Weekly Subcutaneous Ports for the Administration of Anticoagulants

Venous Thromboembolism

United States
d sessler

Terminated

The Effects of Corticosteroids, Glucose Control, and Depth-of-Anesthesia on Perioperative Inflammation and Morbidity From Major Non-cardiac Surgery (Dexamethasone, Light Anesthesia and Tight Glucose Control (DeLiT Trial))

Inflammation | Perioperative Morbidity

United States
Vanderbilt University Medical Center
National Cancer Institute (NCI)

Completed

Metabolic Syndrome in Young Patients With Acute Lymphoblastic Leukemia in Remission

Leukemia | Fatigue | Long-term Effects Secondary to Cancer Therapy in Children

United States
Stanford University
Medtronic

Completed

Assessment of an Automatic Closed-loop Insulin Delivery System

Diabetes Mellitus, Type 1

United States
Novo Nordisk A/S

Completed

A Trial Comparing the Pharmacokinetic Properties of Faster-acting Insulin Aspart (FIAsp) After Different Injection Regions and Routes of Administration in Healthy Subjects

Healthy | Diabetes

Germany
Novo Nordisk A/S

Completed

Effect of Different Insulin Administrations, All in Combination With Metformin, on Glycaemic Control in Subjects With Type 2 Diabetes Inadequately Controlled by Oral Anti-diabetic Drugs

Diabetes Mellitus, Type 2 | Diabetes

Morocco, Tunisia, Algeria, South Africa, Egypt
Novartis

Completed

A Study to Evaluate the Effects of Vildagliptin on the Insulin Response to Glucose in Subjects With Pre-diabetes

Pre-diabetes

United States
Medical University of Vienna

Unknown

The Role of IntraNasal Insulin in Regulating HepaTic Lipid COntent in HUMANS (INTO_humans)

Healthy Subjects

Austria
Universidad del Desarrollo
Clinica Alemana de Santiago

Unknown

MSC Administration for the Management of Type 1 Diabetic Patients (DMT1-MSC)

Type 1 Diabetes Mellitus

Chile
Florida Atlantic University
Advanced Diabetes Treatment Centers; Global Infusions

Withdrawn

Effects of Pulsatile Intravenous Insulin Delivery on Diabetic Neuropathy in pATIENTS (Pts) With Type 1 and Type 2 Diabetes

Diabetic Neuropathy

United States
Tufts Medical Center
National Heart, Lung, and Blood Institute (NHLBI)

Completed

IMMEDIATE Trial - Out of Hospital Administration of Glucose, Insulin and Potassium. (IMMEDIATE)

Myocardial Infarction | Heart Diseases | Cardiovascular Diseases | Coronary Disease | Angina, Unstable | Heart Failure, Congestive

United States
Florida Atlantic University
Advanced Diabetes Treatment Centers

Terminated

Effects of Pulsed Intravenous (IV) Insulin on Brittle and Uncontrolled Diabetes

Diabetes Mellitus

United States
Atlanta VA Medical Center

Unknown

Inpatient Self Monitoring and Administration Study (ISMAS) (ISMAS)

Hyperglycemia | Diabetes Mellitus | Hypoglycemia

United States
Centre Hospitalier Universitaire Vaudois

Unknown

Reappraisal of GIK in Acute STEMI by Pre-hospital Administration (REAGIK-STEMI)

Myocardial Infarction

Switzerland
Merck Sharp & Dohme LLC

Completed

A Study of MK-0893 on Glucagon-Induced Glycemic Excursion in Healthy Male Participants Following Intravenous Administration of Glucagon, Sandostatine® and Insulin (MK-0893-002)

Type 2 Diabetes Mellitus
University of New Mexico
Sanofi

Completed

Comparative Trial Between 3 Types of Insulin Infusion Protocols

Hyperglycemia

United States
University of Cambridge
Medical University of Graz; Profil Institut für Stoffwechselforschung GmbH

Completed

Closing the Loop in Adults With Sub-optimally Controlled Type 1 Diabetes Under Free Living Conditions (AP@home04)

Type 1 Diabetes

United Kingdom, Austria, Germany
Michael Rickels
University of Pennsylvania

Completed

Effect of Short Term Atypical Antipsychotic Administration Compared to Placebo on Hepatic Insulin Extraction

Normal Non-fluency

United States
Foundation for the National Institutes of Health
Eli Lilly and Company; National Institute of Diabetes and Digestive and Kidney... and other collaborators

Unknown

Dynamic Responsiveness of Insulin Secretory Parameters To Sitagliptin and Glimeperide Administration in Type 2 DM

Type 2 Diabetes
Medical University of Graz
European Commission

Completed

Continuous Glucose Sensing at the Site of Subcutaneous Insulin Administration

Type 1 Diabetes

Austria
Texas Tech University Health Sciences Center
Health Resources and Services Administration (HRSA)

Withdrawn

Hispanics With Metabolic Syndrome and Non-ischemic Heart Failure (CHAMP-HF)

Heart Failure | Metabolic Syndrome

United States
University of Tartu

Completed

Effect of Repeated Administration of Liraglutide on Insulinogenic Indices

Healthy

Estonia

Search clinical trials for: insulin administration

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Hong Kong

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations